Sensitive ASX Announcement

Acrux has second generic dossier accepted for review by FDA

Published: 17/10/18, 08:58am (AEST)2 pages
Acrux Limited
ACR:ASXHealthcare

Recent ACR Announcements

Price Sensitive only